IDEX Biometrics ASA
IDXAF
$0.002
$0.001100.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 24.36% | 119.35% | 10.40% | 25.12% | 21.60% |
| Total Depreciation and Amortization | -12.30% | -196.65% | 172.95% | 12.35% | 59.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -480.95% | -1,414.63% | 5,230.00% | -302.39% | 16.72% |
| Change in Net Operating Assets | 4,728.85% | 316.72% | 96.26% | 38.27% | 103.99% |
| Cash from Operations | 9.20% | 68.40% | 29.38% | 23.42% | 44.83% |
| Capital Expenditure | -- | 57.75% | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 102.50% | -89.13% | -78.95% | -41.35% | 11.11% |
| Cash from Investing | -92.50% | 0.00% | 287.22% | -62.30% | 335.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 71.97% | -436.70% | -874.07% | -1,745.12% | -528.81% |
| Issuance of Common Stock | 42.62% | 2,826.15% | -55.42% | -82.87% | -77.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -62.18% | 3,093.18% | -64.91% | -1,596.97% | -17.42% |
| Foreign Exchange rate Adjustments | -190.00% | 191.67% | -- | -200.00% | -78.26% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -87.89% | 86.62% | -127.50% | 4.94% | 8.88% |